Personalized Medicine- Are We There Yet?

May 14, 2010

Location

Clarian Fairbanks Hall: IU/Clarian Education and Resource Center
Parking

Primary Sponsors 

 

Supporting Sponsors

Indiana University School of Medicine

Indiana Clinical Translational Sciences Institute
Notre Dame University
Purdue University

Overview

Personalized Medicine is the next “big thing” in life sciences. Actually, it has been here for a while but the clear pathway for even more effective and efficient personalized or tailored medicine is now before us. Much like advances seen over the years with the adoption of the computer and its many applications, and the Internet, the life sciences industry will see dramatic and creative utilization of the human genome map, health informatics and technology, and a much more effective utilization of diagnostic devices and biomarkers with pharmaceuticals. The result will be a “win-win-win-win-win” for the patient, the doctor, the hospital, the device and diagnostic manufacturers, pharma and the biotech industries, the government or private reimbursers and, of course, the taxpayer. This conference will present interesting and exciting developments that are occurring both here in Indiana and around the globe and review how the state is uniquely situated to be one of the world’s leaders in Personalized Medicine.

Agenda

8:00 am – 9:00 am	Registration and Breakfast
9:00 am – 9:30 am	Overview and Welcome - Personalized Medicine: Health and IT Enablers
	Welcome: Daniel F. Evans, President/CEO, Clarian Health Partners Inc.
	Overview: Charles Kennedy, M.D., Vice President, Health Information Technology, Wellpoint, Inc.
9:30 am – 10:30 am	Keynote Presentation - Personalized Medicine: The Big Picture
	Introduction: Harry L. Gonso, Partner, Ice Miller LLP
	Keynote Speaker: John C. Lechleiter, PhD, Chairman, President and CEO, Eli Lilly and Company
	Q&A
10:30 am – 10:45 am	Break
10:30 am – 12:00 pm	Panel Presentation - The Science Behind the Business of Personalized Medicine
	Moderator: Jane F. Barlow, M.D., M.P.H., MBA,Vice President, Medical Strategy & Clinical Quality, Personalized Medicine, Solutions, Medco, Inc.
	Panel Members:
	George W. Sledge, Jr., M.D.,Ballve-Lantero Professor, IU School of Medicine & Clinical TeamMember, Indiana University Melvin and Bren Simon Cancer Center
	Mark A. Suckow, D.V.M., Director, Freimann Life Science Center, Research Associate Professor, Department of Biological Sciences, University of Notre Dame
	Philip S. Low, PhD, Ralph S. Corley Distinguished Professor-Biochemistry, Purdue University
12:00 pm – 1:30 pm	Lunch & Networking
	Introduction: George W. Sledge, Jr., M.D.
	Speaker: Leroy Hood, M.D., PhD, President, Institute for Systems Biology
1:30 pm – 3:00 pm	Panel Presentation - The Emergence of Personalized Medicine (P4) and How it Will Advance the Medicine of the Future
	Moderator: R. Matthew Neff, President, Clarian Health Ventures, Inc.
	Panel Members:
	Tiffany Olson, Vice President of Diagnostics, Eli Lilly and Company
	P. Ron Ellis, President, Endocyte, Inc.
	Richard H. Selinfreund, PhD, President, Companion Diagnostics, Inc.
	Linda H. Malkas, PhD, Founder, CS-Keys, Inc. and Syntherix, Inc.
3:00 pm - 3:15 pm	Wrap-up Comments
	David L. Johnson, President, CEO, BioCrossroads
3:15 pm - 3:30 pm	Announcement of Topics for 2010-2011
	George Telthorst, Director, Center for the Business of Life Sciences, IU Kelley School of Business